Business · 26/12/2013Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance on Naming of Drug Products Containing Salt Drug Substances
Summary
The Food and Drug Administration (FDA) has announced the availability of a draft guidance for industry on the naming of drug products containing salt drug substances, following the adoption of a new monograph naming policy by the United States Pharmacopeial (U.S.P.) Convention in 2013.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →